Rethinking clinical trial endpoints for evaluating serially delivered ‘strategic radiotherapy’ in oligometastatic or oligoprogressive metastatic disease

Chang, Jeesuk; Wu, Florence T.H.; Ko, Heejoo; Dunne, Emma Maria; Baker, Sarah; Liu, Mitchell C.

doi:10.1016/j.canlet.2025.218106

YUHSpace

BROWSE

0 32

Cited 0 times in

Rethinking clinical trial endpoints for evaluating serially delivered ‘strategic radiotherapy’ in oligometastatic or oligoprogressive metastatic disease

Authors: Chang, Jeesuk ; Wu, Florence T.H. ; Ko, Heejoo ; Dunne, Emma Maria ; Baker, Sarah ; Liu, Mitchell C.

Citation: Cancer Letters, Vol.635, 2025-12

Article Number: 218106

Journal Title: CANCER LETTERS

ISSN: 0304-3835

Issue Date: 2025-12

Abstract: [No abstract available]

Full Text: https://www.sciencedirect.com/science/article/pii/S0304383525006780

DOI: 10.1016/j.canlet.2025.218106

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers

Yonsei Authors: Chang, Jee Suk(장지석) https://orcid.org/0000-0001-7685-3382

URI: https://ir.ymlib.yonsei.ac.kr/handle/22282913/209750

사서에게 알리기

Show full item record Find it @ YMLIB

License

YUHSpace: Rethinking clinical trial endpoints for evaluating serially delivered ‘strategic radiotherapy’ in oligometastatic or oligoprogressive metastatic disease

YUHSpace

BROWSE

Browse

Links